1 / 7

Corticosteroid Implants Macular Edema Market Report to 2023

RnRMarketResearch.com adds “Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023”to its store. Corticosteroids have demonstrated a range of pharmacological actions, including inhibition of inflammation, inhibition of the release of certain inflammatory cytokines, and suppression of VEGF secretion.

rudrak123
Download Presentation

Corticosteroid Implants Macular Edema Market Report to 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 By RnRMarketResearch Browse more reports on Pharmaceuticals athttp://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Corticosteroids have demonstrated a range of pharmacological actions, including inhibition of inflammation, inhibition of the release of certain inflammatory cytokines, and suppression of VEGF secretion, highlighting this type of biological agent as a potential treatment for various ocular conditions, including DME, dAMD, wAMD, and RVO.Corticosteroids have been used off-label for many years as a treatment for ME and wAMD due to their ability to inhibit inflammation and the release of certain inflammatory cytokines, supress VEGF secretion, and reduce the vascular permeability of the retina. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 The three main types of ME are diabetic macular edema (DME), and macular edema following either a central or branch retinal vein occlusion (ME-CRVO and ME-BRVO). Age-related macular degeneration (AMD) is a painless eye condition which leads to gradual, irreversible, loss of central vision, and is one of the leading causes of blindness among people aged 50 and over in the developed world. Currently the ME and AMD markets are dominated by the use of anti-VEGF monotherapy, however, in recent years, corticosteroid implants have been reaching the ME market which could challenge the stronghold these drugs have in this sector. Complete Report is available at http://www.rnrmarketresearch.com/corticosteroid-implants-macular-edema-and-macular-degeneration-forecast-and-market-analysis-to-2023-market-report.html . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Scope: Overview of Macular Edema and Macular Degeneration, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. Detailed information on Corticosteroid Implants including product description, safety and efficacy profiles as well as a SWOT analysis. Sales forecast for Corticosteroid Implants for the top six countries from 2013 to 2023. Sales information covered for the US, France, Germany, Italy, Spain and the UK. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Reasons to Buy: • Understand and capitalize by identifying products that are most likely to ensure a robust return. • Stay ahead of the competition by understanding the changing competitive landscape for Macular Edema and Macular Degeneration. • Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential. • Make more informed business decisions from insightful and in-depth analysis of Corticosteroid Implants performance. • Obtain sales forecast for Corticosteroid Implants from 2013-2023 in top six countries (the US, France, Germany, Italy, Spain and the UK). ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 Table of Contents: 1 Table of Contents 71.1 List of Tables 91.2 List of Figures 102 Introduction 112.1 Related Reports 123 Disease Overview 143.1 Macular Degeneration Overview 143.1.1 Etiology and Pathophysiology 163.1.2 Classification 203.1.3 Symptoms and Diagnosis 223.2 Macular Edema Overview 25 ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  7. Corticosteroid Implants (Macular Edema and Macular Degeneration) – Forecast and Market Analysis to 2023 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related